Status:

COMPLETED

Effects of Berries and Berry Fractions on Metabolic Diseases

Lead Sponsor:

University of Turku

Collaborating Sponsors:

Pakkasmarja

Saarioinen

Conditions:

Type 2 Diabetes

Atherosclerosis

Eligibility:

FEMALE

30-55 years

Phase:

NA

Brief Summary

The study hypothesis is that the bioactive compounds of sea buckthorn berries (Hippophaë rhamnoides), their fractions, and bilberries (Vaccinium myrtillus). have positive effects on lipid and carbohyd...

Detailed Description

The aim of the project was to investigate whether it is possible to reduce the risk of metabolic diseases with supplementing the diet with sea buckthorn berries (Hippophaë rhamnoides), their bioactive...

Eligibility Criteria

Inclusion

  • BMI 26-34
  • total cholesterol 4.5-8 mmol/l
  • LDL chol \>2.5 mmol/l
  • triglycerides \<4 mmol/l
  • glucose \<6 mmol/l
  • insulin \<25 mU/l
  • blood pressure \<160/99 mm Hg
  • hemoglobin \>120 g/l
  • thyroid-stimulating hormone 0.3-4.2 mU/l
  • ALAT \<60 U/l
  • creatinine \<115 umol/l

Exclusion

  • pregnancy
  • menopause,
  • regular smoking
  • previously diagnosed diabetes (other than gestational)
  • thyroid, renal, hematological, or hepatic dysfunction
  • previous myocardial infarction
  • cardiovascular medication
  • treatment with regular medication other than allergy medication or joint lubricates
  • on-going inflammatory disease

Key Trial Info

Start Date :

June 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2009

Estimated Enrollment :

110 Patients enrolled

Trial Details

Trial ID

NCT01860547

Start Date

June 1 2008

End Date

August 1 2009

Last Update

May 22 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Turku, Dept of Biochemistry and Food Chemistry

Turku, Finland, FI-20014